Coming Soon: The TRIPS Waiver Negotiations, A Compilation from Geneva Health Files

THE GENEVA HEALTH FILES BOOK ON THE TRIPS WAIVER NEGOTIATIONS Presenting a comprehensive volume capturing the blow-by-blow account of the TRIPS Waiver discussions at the WTO that unfolded during October 2020-June 2022. This is a compilation of 50 stories from Geneva Health Files on the subject. The book has been put together at the request of several readers of Geneva Health Files, including trade negotiators, academics, and activists. The objective has been to weave together and present the path of these negotiations in a chronological, linear fashion. Nearing 450 pages, the book is being presented as a ready reckoner and a journalistic chronicle … Continue reading Coming Soon: The TRIPS Waiver Negotiations, A Compilation from Geneva Health Files

Deconstructing the TRIPS Waiver Discussions: The Susan Sell Interview

In June 2022, the World Trade Organization adopted a decision at its 12th Ministerial Conference, that could potentially help facilitate easier production of COVID-19 vaccines. This was the outcome of a 20-month long discussion at the WTO on the so-called TRIPS Waiver. But ultimately what resulted was a rather narrow legal mechanism, essentially clarifying existing rules in the WTO TRIPS Agreement. For many, this outcome was not entirely surprising. Susan K Sell from the Australian National University has long examined and explored the nature of the TRIPS Agreement and the politics at the WTO. We spoke with Sell during her recent visit to Geneva … Continue reading Deconstructing the TRIPS Waiver Discussions: The Susan Sell Interview

No Mandate on Extending WTO TRIPS Agreement Decision to Medicines & Tests: The U.S.

The US has expressed its reservations on extending the June Ministerial Decision on the TRIPS Agreement to medicines and tests, going beyond vaccines. At the General Council meeting this week, the US reportedly has said that WTO does not have a mandate and that the decision is limited to whether or not to extend the new rules to medicines and tests. But other countries are keen on discussing ways to adapt and negotiate an outcome so as to include medicines and tests in the scope of the new clarifications. Geneva-based trade officials said that nearly 30 delegations took the floor to discuss … Continue reading No Mandate on Extending WTO TRIPS Agreement Decision to Medicines & Tests: The U.S.

TRIPS Waiver 2.0 at the WTO: Proponents back at the table to push for therapeutics and diagnostics

The embers from the WTO’s 12th ministerial conference are still warm. While the supporters of the original TRIPS waiver are still coming to terms with the remains of the 20 month saga that yielded a ministerial decision clarifying the rules of compulsory licensing for the production of vaccines, they are back at the WTO to stomach another fight. This time, to discuss the way forward to boost the production of therapeutics and diagnostics by seeking to extend the applicability of the June decision to these medical products. This puts the co-sponsors, again, directly in opposition to industry interests where companies such as … Continue reading TRIPS Waiver 2.0 at the WTO: Proponents back at the table to push for therapeutics and diagnostics

Trade Won, Health Did Not. A Sliver of a Waiver at the WTO.

There was jubilation and cheer after the landmark ministerial conference at the WTO which saw a raft of agreements between its 164 members, that some say, has set a new benchmark for success, a kind not witnessed in decades. The outcome also included a weak text clarifying the use of existing rules in the WTO TRIPS Agreement. For the 100-odd countries that supported the original TRIPS waiver proposal, and countless supporters globally, conference was a moment of resignation. It was the culmination of 20 months of a fight that saw sustained resistance from many developed countries that refused to waive intellectual property … Continue reading Trade Won, Health Did Not. A Sliver of a Waiver at the WTO.

So Close, Yet So Far: TRIPS Waiver at the WTO

Proposed Waiver Text in Ministers’ Hand, Key Differences Remain Less than 24 hours before the 12th Ministerial Conference gets underway in Geneva – the capital of global health, and the seat of pandemic policy-making – WTO members continue to disagree on key aspects of the organization’s response to the pandemic, including an agreement on a potential waiver of a provision of the TRIPS Agreement. The discussions on the TRIPS Waiver remain on tenterhooks, as ministers will now consider a bracketed text, the WTO reported last night. Key differences remain on how to adapt international trade rules meant to protect intellectual property rights in … Continue reading So Close, Yet So Far: TRIPS Waiver at the WTO

Is the delay the defeat of the TRIPS Waiver discussions at the WTO?

With barely 10 days left for the WTO ministerial conference, countries are increasingly under pressure to arrive at a consensus on the text proposed by DG Ngozi Okonjo-Iweala. Members have met in small group discussions over the last few weeks, that have included participation of up to 30 members. Countries with smaller delegations have been spread thin across multiple, parallel negotiations at the WTO in the run up to the ministerial conference (12-15 June 2022) including for disciplines such as agriculture, fisheries among others. This analysis is based on the negotiations the version of the text dated May 30, seen … Continue reading Is the delay the defeat of the TRIPS Waiver discussions at the WTO?

China’s Spokes WTO Quad Waiver Text, Offers to Sidestep if Conditions Met

China, one of the biggest exporters of COVID-19 vaccines, told WTO members this week that it has concerns on an exports-based eligibility criterion that seeks to exclude developing countries that export more than 10% of the world’s vaccines – a condition that has been proposed as a part of the “Quad waiver text”, now being negotiated at the WTO. China said that “using the criterion of export share to define eligible members will send a wrong signal to the outside world and also have systemic implications to the future negotiations”. China also offered that if its concerns on such a … Continue reading China’s Spokes WTO Quad Waiver Text, Offers to Sidestep if Conditions Met

China’s Spokes WTO Quad Waiver Text, Offers to Sidestep if Conditions Met

China, one of the biggest exporters of COVID-19 vaccines, told WTO members this week that it has concerns on an exports-based eligibility criterion that seeks to exclude developing countries that export more than 10% of the world’s vaccines – a condition that has been proposed as a part of the “Quad waiver text”, now being negotiated at the WTO. China said that “using the criterion of export share to define eligible members will send a wrong signal to the outside world and also have systemic implications to the future negotiations”. China also offered that if its concerns on such a … Continue reading China’s Spokes WTO Quad Waiver Text, Offers to Sidestep if Conditions Met

WTO DG Serves Up New Proposed Text on the TRIPS Waiver to a Divided House, Tense Negotiations Expected

This week WTO members were given access to a letter that was described as an outcome document based on the discussions between select members. This letter was sent by the Director General Ngozi Okonjo-Iweala to the Chair of the Council for Trade-Related Aspects of Intellectual Property Rights, Ambassador Lansana Gberie of Sierra Leone, describing the progress of the informal discussions on the TRIPS Waiver proposal. The letter also shared a proposed text by the DG on the waiver discussions.   Although the document does not specifically mention the quadrilateral group (comprising the US, the EU, India and South Africa) it is understood … Continue reading WTO DG Serves Up New Proposed Text on the TRIPS Waiver to a Divided House, Tense Negotiations Expected